Projects funded by the NCN
Selective PPARγ modulation by amorfrutin B as a novel therapeutic approach to chemotherapy-induced damage to mammalian brain cells
2023/49/N/NZ7/03640
Keywords:
neuroprotection neurotoxicity chemotherapy-induced brain cell damage PPARγ apoptosis autophagy epigenetic status
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ3_5: Molecular neurobiology
- NZ3_3: Apoptosis
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 22 - announced on 2023-03-16
Amount awarded: 210 000 PLN
Project start date (Y-m-d): 2024-01-29
Project end date (Y-m-d): 2027-01-28
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.